Bendtzen, Klaus

Monitoring patients treated with anti-TNF- biopharmaceuticals: assessing serum infliximab and anti-infliximab antibodies

Svenson, M., Geborek, P., Saxne, T., & Bendtzen, K. (2007) · Rheumatology

Biosimilars and Bioanalytical MethodsRheumatoid Arthritis Research and Therapies

Cited by 189

Inhibition of human lymphocyte proliferation and cleavage of interleukin-2 by Pseudomonas aeruginosa proteases

Theander, T. G., Kharazmi, A., Pedersen, B. K., Christensen, L. D., Tvede, N., Poulsen, L. K., Odum, N., Svenson, M., & Bendtzen, K. (1988) · Infection and Immunity

Bacterial biofilms and quorum sensingProtease and Inhibitor Mechanisms

Cited by 83

Immunogenicity of Anti-TNF-α Biotherapies: II. Clinical Relevance of Methods Used for Anti-Drug Antibody Detection

Bendtzen, K. (2015) · Frontiers in Immunology

Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research

Cited by 73

Enhancement of Human Adaptive Immune Responses by Administration of a High-Molecular-Weight Polysaccharide Extract from the Cyanobacterium Arthrospira platensis

Løbner, M., Walsted, A., Larsen, R., Bendtzen, K., & Nielsen, C. H. (2008) · Journal of Medicinal Food

Seaweed-derived Bioactive CompoundsImmunotherapy and Immune Responses

Cited by 66

Biological anti-TNF drugs: immunogenicity underlying treatment failure and adverse events

Prado, M. S., Bendtzen, K., & Andrade, L. E. C. (2017) · Expert Opinion on Drug Metabolism & Toxicology

Biosimilars and Bioanalytical MethodsMonoclonal and Polyclonal Antibodies Research

Cited by 58